Literature DB >> 17098302

Brain leptin resistance in human obesity revisited.

N Eikelis1, G Wiesner, G Lambert, M Esler.   

Abstract

Leptin is a 16 kDa peptide predominantly produced by adipocytes. Leptin and its receptor are known to be involved in the regulation of energy balance. The data from animal studies as well as our own observations of leptin overflow from the brain suggest that the central nervous system is a site of leptin synthesis. Using simultaneous arterio-venous blood sampling we here confirm that leptin is released from the brain into the internal jugular vein, and that release is greater in overweight men and in females compared to lean men, 467.3 ng/min+/-160.4 and 1426 ng/min+/-769.3 vs 80.0 ng/min+/-29.3, respectively (P<0.05). Furthermore, we have examined the gene expression of leptin and its receptor isoforms by reverse transcription-polymerase chain reaction (RT-PCR) in human cadaver hypothalami across a broad range of adiposity. Leptin gene expression was detected in a number of donors; the presence of detectable leptin mRNA was related to the mode of death rather than BMI or gender. We have also demonstrated gene expression of the three leptin receptor isoforms in the human hypothalamus. No relation was observed between the levels of hypothalamic expression of the long signaling form of the leptin receptor and BMI. In summary, this study indicates that it is very difficult to explain human obesity on the basis of central nervous system "leptin resistance", in that leptin is released in the brain, and at a higher level in the obese, and brain leptin receptor gene expression is not impaired in obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098302     DOI: 10.1016/j.regpep.2006.10.003

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  9 in total

1.  NMDA receptor subunit composition determines the polarity of leptin-induced synaptic plasticity.

Authors:  Peter R Moult; Jenni Harvey
Journal:  Neuropharmacology       Date:  2011-07-05       Impact factor: 5.250

2.  Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats.

Authors:  J C Russell; S D Proctor
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

3.  Leptin in hippocampus mediates benefits of mild exercise by an antioxidant on neurogenesis and memory.

Authors:  Jang Soo Yook; Randeep Rakwal; Junko Shibato; Kanako Takahashi; Hikaru Koizumi; Takeru Shima; Mitsushi J Ikemoto; Leandro K Oharomari; Bruce S McEwen; Hideaki Soya
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-13       Impact factor: 11.205

4.  Contributions of the hippocampus and medial prefrontal cortex to energy and body weight regulation.

Authors:  Terry L Davidson; Kinho Chan; Leonard E Jarrard; Scott E Kanoski; Deborah J Clegg; Stephen C Benoit
Journal:  Hippocampus       Date:  2009-03       Impact factor: 3.899

Review 5.  Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions.

Authors:  Satya P Kalra
Journal:  Peptides       Date:  2007-10-24       Impact factor: 3.750

6.  Endurance exercise is a leptin signaling mimetic in hypothalamus of Wistar rats.

Authors:  Jiexiu Zhao; Ye Tian; Jincheng Xu; Dongsen Liu; Xiaofang Wang; Binxiu Zhao
Journal:  Lipids Health Dis       Date:  2011-12-02       Impact factor: 3.876

7.  Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?

Authors:  Marià Alemany
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-27       Impact factor: 5.555

8.  Leptin Induces a Novel Form of NMDA Receptor-Dependent LTP at Hippocampal Temporoammonic-CA1 Synapses

Authors:  Xiao Luo; Gemma McGregor; Andrew J Irving; Jenni Harvey
Journal:  eNeuro       Date:  2015-06-10

9.  Leptin regulates AMPA receptor trafficking via PTEN inhibition.

Authors:  Peter R Moult; Alasdair Cross; Sandra D Santos; Ana-Luisa Carvalho; Yvonne Lindsay; Christopher N Connolly; Andrew J Irving; Nicholas R Leslie; Jenni Harvey
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.